Sanai Health Industry Group Company Limited

WUP0 · F · Healthcare / Drug Manufacturers - Specialty & Generic

0.016EUR+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close0.016

Open0.016

Day Range0.016 – 0.016

52-Week Range0.014 – 0.039

Volume0

Market Cap3.21M

P/E (TTM)2.10

Forward P/E10.87

EPS0.01

Dividend Yield0.00%

Beta-1.08

50-Day Avg0.025

200-Day Avg0.025

About

Sanai Health Industry Group Company Limited, an investment holding company, engages in the manufacture, marketing, and sale of branded prescription and non-prescription drugs, and Chinese pharmaceutical products in the People's Republic of China and Hong Kong. It operates through Pharmaceutical Products and Finance Leasing segments. The company is involved in development, manufacturing, marketing, and sales of pharmaceutical products; sale of pharmaceutical related software; and provision of consultancy services. It also provides finance leasing services; and engages in the research, production, and sale of health products, functional foods, and skincare products in the field of soft capsule dosage form. Sanai Health Industry Group Company Limited was incorporated in 2006 and is based in Kwun Tong, Hong Kong.

Company Details

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CEOMr. Chaoyang Yuan
Employees140
HeadquartersNanyang Plaza, Kwun Tong, Hong Kong, Germany
Websitehttps://www.1889hk.com

Leadership

Mr. Chaoyang YuanExecutive Director · b. 1973
Mr. Haijing XieExecutive Director · b. 1972
Ms. Yuen Fong ChanCompany Secretary

Financials

Income Statement

Currency: CNY	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	67.61M	175.92M	107.77M	85.22M	85.90M
Growth (%)	-	+160.21%	-38.74%	-20.92%	+0.80%
Cost of Revenue	27.05M	84.25M	78.54M	68.35M	71.57M
Gross Profit	40.55M	91.67M	29.22M	16.86M	14.33M
Gross Margin	59.99%	52.11%	27.12%	19.79%	16.69%
Operating Expense	14.84M	30.27M	10.77M	28.02M	36.98M
Operating Income	25.72M	61.41M	18.45M	-11.15M	-22.65M
Operating Margin	38.04%	34.91%	17.12%	-13.09%	-26.37%
EBITDA	-	61.09M	25.47M	-7.59M	-20.23M
EBITDA Margin	-	34.72%	23.64%	-8.91%	-23.56%
Net Income	9.03M	29.22M	18.63M	4.89M	-22.04M
Net Income Margin	13.35%	16.61%	17.29%	5.74%	-25.66%
Interest Expense	0	1.79M	2.03M	2.20M	2.82M
Interest Expense % of Total Revenue	0.00%	1.02%	1.88%	2.58%	3.28%

Balance Sheet

Currency: CNY	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	311.24M	384.82M	383.44M	468.96M	421.73M
Total Liabilities	91.69M	128.74M	113.77M	117.36M	97.63M
Total Equity	199.07M	245.59M	264.45M	321.99M	298.26M
Cash	16.30M	21.84M	332.47M	340.43M	298.60M
Net Debt	-	47.90M	-	-	-

Cash Flow

Currency: CNY	2007-12-31	2008-12-31	2009-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	-	-	-	-38.73M	-56.19M	320.69M	11.80M	-53.24M
Capital Expenditure	0	0	0	73.00K	27.00K	82.00K	1.17M	1.13M
Free Cash Flow	-	-	-	-38.81M	-56.22M	320.61M	10.63M	-54.36M
FCF to OCF	-	-	-	100.19%	100.05%	99.97%	90.05%	102.12%

Key Statistics & Ratios

Market Cap3.21M

Enterprise Value-31.90M

Trailing P/E2.10

Forward P/E10.87

Price / Sales0.04

Price / Book0.11

EPS0.01

Book Value0.1452

Revenue (TTM)82.60M

Gross Profit (TTM)20.52M

EBITDA-15.65M

Profit Margin-23.59%

Operating Margin-16.38%

Return on Equity-7.99%

Return on Assets-2.48%

Shares Outstanding152.90M

Shares Float104.02M

Beta-1.08

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%

Dividends

20121×

0.02Jun 26, 2012

20112×

0.25Aug 1, 20110.04May 30, 2011

Stock Splits

Aug 13, 20241:25